Pharmagroup Int. and Fluvera: When subsidiary governance means losing competitive ground
Pharmagroup Int. faces difficulties in finishing the development and getting to the market an new, strategically important product. The product was created by a US start up, that had originally formed a strategic Joint Venture with Pharmagroup, but was then more and more integrated into the group because of difficulties in R&D that Pharmagroup was unable to control and overcome. Now, R&D takes place in a fully owned US subsidiary but Pharmagroup is still unable to make considerable progress with the current governance system. The learning objective is to understand the importance of subsidiary governance and its business dimension in multinational groups, to identify key problems and causes in the setting and to design a subsidiary governance system for the US operations that leads to efficient and timely conclusion of development and market launch.
Healthcare, Pharmaceuticals
1998-2006
Cranfield University
Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]
Harvard Business School Publishing
60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]
NUCB Business School
1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
Research Information & Knowledge Hub for additional information on IMD publications
Medacta Group SA is a rising star in the orthopedics market, achieving global success through innovative products and techniques, with a particular emphasis on minimally invasive techniques that bring meaningful value to its patients. With its app...
The case study introduces an original way of exploring the many questions and concerns around AI adoption in business. Based on a true story, it discusses the dilemma of AI implementation through Joe, the CIO of ParcelFlow. Joe is getting ready to...
This case study explores AstraPay’s journey to become a significant player, despite its latecomer status, in Indonesia’s burgeoning digital payments landscape. Launched in 2018, AstraPay had grown to serve over one million customers, but it faced ...
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications
Case reference: IMD-2663 ©2025
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Case reference: IMD-2650 ©2025
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications